NUVB
NUVB
NYSE · Pharmaceuticals

Nuvation Bio Inc

$5.71
-0.39 (-6.39%)
As of Sep 23, 10:04 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +656.9% upside
Low Target $30.63
Average Target $43.22
High Target $69.64
Current Price $5.71
Current
$5.71
Target
$43.22
$30.63 $43.22 avg $69.64
Scenario Analysis
Bear Case
$30.63
436.4%
Low target
Base Case
$43.22
+656.9%
Avg target
Bull Case
$69.64
+1,119.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.75
-41.4% from high
52-Week Low
$2.99
+91.0% from low
Target vs 52W High
$43.22
+343.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%